Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.

Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, Ujszaszi A, Kiss I, Rosivall L, Kosa J, Lakatos P, Kovesdy CP, Mucsi I.

J Am Soc Nephrol. 2011 May;22(5):956-66. doi: 10.1681/ASN.2010080894. Epub 2011 Mar 24.

PMID:
21436289
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

Sánchez Fructuoso AI, Maestro ML, Pérez-Flores I, Valero R, Rafael S, Veganzones S, Calvo N, De la Orden V, De la Flor JC, Valga F, Vidaurreta M, Fernández-Pérez C, Barrientos A.

Nephrol Dial Transplant. 2012 Nov;27(11):4227-35. doi: 10.1093/ndt/gfs409.

PMID:
23144073
[PubMed - indexed for MEDLINE]
Free Article
3.

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.

Baia LC, Humalda JK, Vervloet MG, Navis G, Bakker SJ, de Borst MH; NIGRAM Consortium.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1968-78. doi: 10.2215/CJN.01880213. Epub 2013 Aug 8.

PMID:
23929933
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M.

Kidney Int. 2011 Jun;79(12):1370-8. doi: 10.1038/ki.2011.47. Epub 2011 Mar 9. Erratum in: Kidney Int. 2012 Aug;82(4):498.

PMID:
21389978
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.

Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, Tsubakihara Y, Rakugi H, Takahara S, Isaka Y.

Bone. 2012 Oct;51(4):729-36. doi: 10.1016/j.bone.2012.06.027. Epub 2012 Jul 14.

PMID:
22796419
[PubMed - indexed for MEDLINE]
6.

Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.

Sánchez Fructuoso AI, Maestro ML, Calvo N, De La Orden V, Pérez Flores I, Vidaurreta M, Valero R, Fernández-Pérez C, Barrientos A.

Transplant Proc. 2012 Nov;44(9):2551-4. doi: 10.1016/j.transproceed.2012.09.070.

PMID:
23146451
[PubMed - indexed for MEDLINE]
7.

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.

Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE.

Eur J Endocrinol. 2008 Jan;158(1):125-9. doi: 10.1530/EJE-07-0534.

PMID:
18166826
[PubMed - indexed for MEDLINE]
Free Article
8.

Renal phosphate loss in long-term kidney transplantation.

Sirilak S, Chatsrisak K, Ingsathit A, Kantachuvesiri S, Sumethkul V, Stitchantrakul W, Radinahamed P, Disthabanchong S.

Clin J Am Soc Nephrol. 2012 Feb;7(2):323-31. doi: 10.2215/CJN.06380611. Epub 2011 Dec 1.

PMID:
22134626
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Okada N, Tsubakihara Y, Isaka Y, Rakugi H.

Clin J Am Soc Nephrol. 2012 May;7(5):810-9. doi: 10.2215/CJN.08680811. Epub 2012 Feb 23.

PMID:
22362065
[PubMed - indexed for MEDLINE]
Free Article
10.

Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.

Nakano C, Hamano T, Fujii N, Obi Y, Matsui I, Tomida K, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Okada N, Tsubakihara Y, Rakugi H, Isaka Y.

Bone. 2012 Jun;50(6):1266-74. doi: 10.1016/j.bone.2012.02.634. Epub 2012 Mar 6.

PMID:
22425694
[PubMed - indexed for MEDLINE]
11.

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.

Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.

Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4.

PMID:
23129826
[PubMed - indexed for MEDLINE]
Free Article
12.

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.

J Am Soc Nephrol. 2007 Sep;18(9):2600-8. Epub 2007 Jul 26.

PMID:
17656479
[PubMed - indexed for MEDLINE]
Free Article
13.

Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?

Wesseling-Perry K, Tsai EW, Ettenger RB, Jüppner H, Salusky IB.

Nephrol Dial Transplant. 2011 Nov;26(11):3779-84. doi: 10.1093/ndt/gfr126. Epub 2011 Mar 25.

PMID:
21441401
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Group.

JAMA. 2011 Jun 15;305(23):2432-9. doi: 10.1001/jama.2011.826.

PMID:
21673295
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

FGF-23 levels in patients with AKI and risk of adverse outcomes.

Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S, Stern L.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1217-23. doi: 10.2215/CJN.00550112. Epub 2012 Jun 14.

PMID:
22700885
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Regulation of fibroblast growth factor-23 in chronic kidney disease.

Westerberg PA, Linde T, Wikström B, Ljunggren O, Stridsberg M, Larsson TE.

Nephrol Dial Transplant. 2007 Nov;22(11):3202-7. Epub 2007 Jun 13.

PMID:
17567652
[PubMed - indexed for MEDLINE]
Free Article
17.

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.

Lundberg S, Qureshi AR, Olivecrona S, Gunnarsson I, Jacobson SH, Larsson TE.

Clin J Am Soc Nephrol. 2012 May;7(5):727-34. doi: 10.2215/CJN.10331011. Epub 2012 Mar 1.

PMID:
22383747
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.

Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, Chen J, Feldman H, Gutierrez OM, Lash J, Leonard MB, Negrea L, Rosas SE, Anderson AH, Townsend RR, Wolf M, Isakova T; Chronic Renal Insufficiency Cohort Study Group.

Diabetes Care. 2012 May;35(5):994-1001. doi: 10.2337/dc11-2235. Epub 2012 Mar 23.

PMID:
22446176
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?

Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Jüppner H, Wolf M.

Kidney Int. 2006 Oct;70(8):1486-94. Epub 2006 Aug 30.

PMID:
16941023
[PubMed - indexed for MEDLINE]
20.

The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.

Bacchetta J, Dubourg L, Harambat J, Ranchin B, Abou-Jaoude P, Arnaud S, Carlier MC, Richard M, Cochat P.

J Clin Endocrinol Metab. 2010 Apr;95(4):1741-8. doi: 10.1210/jc.2009-1576. Epub 2010 Feb 15.

PMID:
20157196
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk